$LDSN
Luduson G Inc.

2023 Q3 Form 10-Q Financial Statement

#000168316823005789 Filed on August 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit Margin
Selling, General & Admin $210.8K $3.330K
YoY Change 54.67% -96.41%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Operating Expenses $210.8K $3.330K
YoY Change 54.67% -96.41%
Operating Profit -$210.8K -$3.330K
YoY Change 71.53% -95.83%
Interest Expense $6.657K
YoY Change 166325.0%
% of Operating Profit
Other Income/Expense, Net -$6.651K $0.00
YoY Change -183.72% -100.0%
Pretax Income -$217.4K -$3.325K
YoY Change 89.17% -92.86%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$217.4K -$3.325K
YoY Change 89.17% -92.86%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 28.21M shares 28.21M shares
Diluted Shares Outstanding 465.5M shares 28.21M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $232.2K
YoY Change 7691.95%
Cash & Equivalents $232.2K $0.00
Short-Term Investments
Other Short-Term Assets $64.10K
YoY Change -95.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $296.3K $0.00
YoY Change -80.46% -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $806.2K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.806M $0.00
YoY Change 4535.68% -100.0%
TOTAL ASSETS
Total Short-Term Assets $296.3K $0.00
Total Long-Term Assets $6.806M $0.00
Total Assets $7.102M $0.00
YoY Change 327.07% -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.52K
YoY Change -39.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $78.93K
YoY Change
Total Short-Term Liabilities $151.5K $81.50K
YoY Change -83.95% -91.51%
LONG-TERM LIABILITIES
Long-Term Debt $1.023M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.023M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $151.5K $81.50K
Total Long-Term Liabilities $1.023M
Total Liabilities $1.174M $81.50K
YoY Change 24.39% -91.51%
SHAREHOLDERS EQUITY
Retained Earnings -$14.26M -$1.117M
YoY Change 4620.89% 496.66%
Common Stock $49.61K $2.821K
YoY Change 1658.49% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.928M -$81.50K
YoY Change
Total Liabilities & Shareholders Equity $7.102M $0.00
YoY Change 327.07% -100.0%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$217.4K -$3.325K
YoY Change 89.17% -92.86%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Operating Activities -$72.46K -$2.820K
YoY Change 35.21% -133.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.820K
YoY Change
Cash From Investing Activities -$2.820K $2.820K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 295.4K
YoY Change 2597.99%
NET CHANGE
Cash From Operating Activities -72.46K -2.820K
Cash From Investing Activities -2.820K 2.820K
Cash From Financing Activities 295.4K
Net Change In Cash 220.2K 0.000
YoY Change -616.3% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$72.46K -$2.820K
Capital Expenditures $0.00
Free Cash Flow -$72.46K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001737193
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Depreciation
Depreciation
0 usd
CY2022Q2 us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38457
dei Entity Registrant Name
EntityRegistrantName
Luduson G Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3184409
dei Entity Address Address Line1
EntityAddressAddressLine1
35/F, Central Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
18 Harbour Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Wanchai
dei Entity Address Country
EntityAddressCountry
HK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
00000
dei City Area Code
CityAreaCode
+852
dei Local Phone Number
LocalPhoneNumber
2824 8560
dei Security12b Title
Security12bTitle
Common Stock, par value US$0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28210000 shares
CY2023Q2 LDSN Investment In Unlisted Shares
InvestmentInUnlistedShares
0 usd
CY2022Q4 LDSN Investment In Unlisted Shares
InvestmentInUnlistedShares
2821 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
0 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2821 usd
CY2023Q2 us-gaap Assets
Assets
0 usd
CY2022Q4 us-gaap Assets
Assets
2821 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
81504 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
81000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
81504 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
81000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
81504 usd
CY2022Q4 us-gaap Liabilities
Liabilities
81000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28210000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28210000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28210000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28210000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2821 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2821 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1032179 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1032179 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1116504 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1113179 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-81504 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-78179 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2821 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3325 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3325 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3325 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3325 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3325 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-3325 usd
us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28210000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28210000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28210000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28210000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28210000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28210000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28210000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28210000 shares
us-gaap Net Income Loss
NetIncomeLoss
-3325 usd
us-gaap Net Income Loss
NetIncomeLoss
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
504 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2821 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
LDSN Disposal Of Investment In Unlisted Shares
DisposalOfInvestmentInUnlistedShares
2821 usd
LDSN Disposal Of Investment In Unlisted Shares
DisposalOfInvestmentInUnlistedShares
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2821 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-35179 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-35179 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-35179 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-78179 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-78179 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3325 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-81504 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zXIWHdnlIvve" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 29.4pt; text-align: justify; text-indent: -30.1pt"><span style="font-family: Wingdings">l</span>   <span id="xdx_86A_zvRo4JeBjBll">Use of estimates and assumptions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p>
LDSN Property Plant And Equipment Estimated Useful Lives1
PropertyPlantAndEquipmentEstimatedUsefulLives1
5 years
us-gaap Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure
RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure
<p id="xdx_848_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_zklQROmn4vjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify; text-indent: -27pt"><span style="font-family: Wingdings">l</span>   <span id="xdx_86D_zjWMKGC3krfh">Revenue recognition</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted Accounting Standards Codification (“ASC<i>”) 606 – Revenue from Contracts with Customers</i>” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the contract with a customer;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determine the transaction price;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28210000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28210000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28210000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28210000 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2500000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2500000 shares

Files In Submission

Name View Source Status
0001683168-23-005789-index-headers.html Edgar Link pending
0001683168-23-005789-index.html Edgar Link pending
0001683168-23-005789.txt Edgar Link pending
0001683168-23-005789-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ldsn-20230630.xsd Edgar Link pending
ldsnlogo.jpg Edgar Link pending
luduson_ex3101.htm Edgar Link pending
luduson_ex3102.htm Edgar Link pending
luduson_ex3201.htm Edgar Link pending
luduson_ex3202.htm Edgar Link pending
luduson_i10q-063023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ldsn-20230630_def.xml Edgar Link unprocessable
ldsn-20230630_cal.xml Edgar Link unprocessable
ldsn-20230630_lab.xml Edgar Link unprocessable
ldsn-20230630_pre.xml Edgar Link unprocessable
luduson_i10q-063023_htm.xml Edgar Link completed